TrialBritish journal of haematology2022

Daratumumab plus lenalidomide, bortezomib and dexamethasone in newly diagnosed multiple myeloma: Analysis of vascular thrombotic events in the GRIFFIN study.

Douglas W Sborov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.